Tumoral overexpression of CCL19, CCL21, and XCL1 significantly increased ratios of total cDCs, cDC1, and cDC2 subtypes among CD45+ leukocytes in the TME, as compared to the empty vector control tumors (Figure 5A and 5B). The gene discussed is CCL19; the disease is neoplasm.